Comparative effectiveness of neuraxial versus general anesthesia in total joint replacement surgery: an updated retrospective analysis using more recent data

Reg Anesth Pain MedPublished Retrospective cohort study

Authors' conclusion

These findings re-confirm our study group's decade-old study using more recent data and offer additional evidence toward the sustained benefit of neuraxial anesthesia in major orthopedic surgery.

Study context

Population
Elective THA/TKA patients, all-payor Premier Healthcare Database, 2006 to 2021THAs 587,919 and 499,484
Exposure
Neuraxial vs general anaesthesia for elective THA/TKA
Outcome
Adverse outcomes:
  • PE
  • Cerebrovascular events
  • Pulmonary compromise
  • Cardiac complications
  • Acute MI
  • Pneumonia
  • All infections
  • Acute renal failure
  • Gastrointestinal complications
  • Postoperative mechanical ventilation
  • ICU admissions
  • Blood transfusions
Methodological detailsmultivariable regression, Premier Healthcare Database
  • Multivariable regression
  • Premier Healthcare Database

Main finding

As reported in the abstract

Adverse outcomes among THAs, neuraxial vs general
Neuraxial vs GeneralOdds ratio (CI)P value
Acute renal failure, 2006-2015
0.72(0.65–0.80)
P < 0.001
Acute renal failure, 2016-2021
0.56(0.50–0.63)
P < 0.001
Blood transfusion, 2006-2015
0.91(0.89–0.94)
P < 0.001
Blood transfusion, 2016-2021
0.44(0.41–0.47)
P < 0.001

Observational data: associations, not effects.

Further findings

Neuraxial anaesthesia use among THAs

Use in 2006
10.7%
Use in 2021
25.7%

Adverse outcomes among TKAs (subgroup)

Similar patterns existed for TKAs

Original publication

Comparative effectiveness of neuraxial versus general anesthesia in total joint replacement surgery: an updated retrospective analysis using more recent data. Reg Anesth Pain Med. Published 8 July 2024. doi:10.1136/rapm-2024-105438

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.